Board notes shareholder requisitions for EGM on Chairman appointment and MD remuneration
Board meeting on 30 Sep 2026 took note of two shareholder requisition letters received on 24 Sep 2026 for calling an EGM.
- Shareholder Requisition 1 Holding
- 38.41%
- Shareholder Requisition 1 Request
- Appointment of Mr. Arun Purushottam Kelkar as Executive Director and Chairman
- Shareholder Requisition 2 Holding
- 24.67%
- Shareholder Requisition 2 Request
- Approval of remuneration for MD Mr. Vikram Kelkar, effective 1 April 2026
- Trading Window Closure
- 1 Oct 2026 till 48 hours after Q2 results
What the Board took note of
The Board of Directors met on September 30, 2026 and considered two requisition letters received on September 24, 2026 under Section 100 of the Companies Act, 2013 — a provision that lets qualifying shareholders require the company to call an Extra-ordinary General Meeting (EGM).
- Requisition 1: from Dr. Nikhil Arun Kelkar and Mr. Vikram Arun Kelkar, holding together 38.41% of the shareholding. It seeks appointment of Mr. Arun Purushottam Kelkar as Executive Director and Chairman, following a notice of candidature under Section 160(1), and approval of his remuneration for the term of appointment.
- Requisition 2: from Dr. Nikhil Arun Kelkar and Ms. Anuradha Kelkar, holding together 24.67% of the shareholding. It seeks approval of remuneration payable to Mr. Vikram Kelkar, Managing Director, with effect from 1st April 2026.
The Board also considered the proposal for convening an EGM to seek members' approval on these matters.
Meeting timing
The meeting began at 11:00 A.M. and concluded at 11:50 A.M.
Trading window
The trading window for directors, officers, designated persons and their immediate relatives remains closed from Thursday, October 1, 2026 until 48 hours after declaration of financial results for the quarter ended September 30, 2026. This is a routine insider-trading safeguard and does not affect ordinary public shareholders.
How investors may read it
These are governance and board-composition items driven by shareholders from the promoter family. The actual appointment and remuneration amounts will require member approval at the EGM. Investors may watch for the EGM notice, which would carry the proposed remuneration terms and meeting date.
Also from Hexagon Nutrition
Letters dispatched to shareholders without registered e-mail, giving web-link to EGM Notice
7 Oct 2026
EGM on 28 October 2026 to vote on Chairman appointment and remuneration of two Kelkar directors
6 Oct 2026
Commercial-scale process validation of PFH-VAP completed; to be marketed as VIT A+
29 Sep 2026
More numbers
- Shareholding of requisitionists (Requisition 1)38.41%
- Shareholding of requisitionists (Requisition 2)24.67%
- Trading window reopens after results48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.